Literature DB >> 21154256

Prognostic significance of cardiac magnetic resonance imaging: Update 2010.

Vinzenz Hombach1, Nico Merkle, Peter Bernhard, Volker Rasche, Wolfgang Rottbauer.   

Abstract

Cardiac magnetic resonance imaging (CMR) has become an indispensible imaging technique for the diagnosis and treatment of patients with cardiovascular diseases. Technical advances in the past have rendered CMR unique in the evaluation of cardiovascular anatomy, physiology, and pathophysiology due to its unique ability to produce high resolution tomographic images of the human heart and vessels in any arbitrary orientation, with soft tissue contrast that is superior to competing imaging modalities without the use of ionizing radiation. CMR imaging is the gold standard for assessing left and right ventricular function and for detecting myocardial tissue abnormalities like edema, infarction, or scars. For prognostic reasons abnormal structure and dysfunction of the heart, and the detection of myocardial ischemia and/ /or myocardial scars are the main targets for CMR imaging. In this review we briefly describe the prognostic significance of several CMR imaging techniques and special CMR parameters in patients with coronary artery disease (CAD), with cardiomyopathies, and with chronic heart failure. Myocardial ischemia proved to be a strong predictor of an adverse outcome in patients with CAD. Microvascular obstruction in acute myocardial infarction is a new and independent parameter of negative left ventricular remodeling and a worse prognosis. Myocardial scars in patients with CAD and unrecognized myocardial infarction heralds a negative outcome. Scar in patients with dilated or hypertrophic cardiomyopathy are a strong predictor of both life-threatening ventricular tachyarrhythmias and prognosis. CMR imaging may improve the assessment of inter- and intraventricular dyssynchrony and provide prognostic information by detecting myocardial scars.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21154256

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  15 in total

1.  Transferrin-coated gadolinium nanoparticles as MRI contrast agent.

Authors:  Huedayi Korkusuz; Karsten Ulbrich; Katerina Welzel; Verena Koeberle; Waralee Watcharin; Ute Bahr; Valery Chernikov; Thomas Knobloch; Sabine Petersen; Frank Huebner; Hanns Ackermann; Svetlana Gelperina; Wolfgang Kromen; Renate Hammerstingl; Joerg Haupenthal; Frank Gruenwald; Jens Fiehler; Stefan Zeuzem; Joerg Kreuter; Thomas J Vogl; Albrecht Piiper
Journal:  Mol Imaging Biol       Date:  2013-04       Impact factor: 3.488

2.  Relation of plasma adiponectin levels and aortic stiffness after acute ST-segment elevation myocardial infarction.

Authors:  S J Reinstadler; G Klug; H J Feistritzer; A Mayr; K Bader; J Mair; R Esterhammer; M Schocke; B Metzler
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-12-04

3.  Relationship between quality of coronary collateral and myocardial viability in chronic total occlusion: a magnetic resonance study.

Authors:  Khaled Abdel-Azim Shokry; El-Sayed Mohamed Farag; Ahmed Mohamed Hassan Salem; Mahmoud Abdelaziz; Ahmed El-Zayat; Ismail Mohamed Ibrahim
Journal:  Int J Cardiovasc Imaging       Date:  2020-09-17       Impact factor: 2.357

4.  The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study.

Authors:  Alberto Palazzuoli; Matteo Beltrami; Luigi Gennari; A Ghosh Dastidar; Ranuccio Nuti; Elisa McAlindon; Gianni D Angelini; Chiara Bucciarelli-Ducci
Journal:  Int J Cardiovasc Imaging       Date:  2015-04-12       Impact factor: 2.357

5.  Association of cardiovascular disease risk factors with left ventricular mass, biventricular function, and the presence of silent myocardial infarction on cardiac MRI in an asymptomatic population.

Authors:  Eliel Nham; Sung Mok Kim; Sang-Chol Lee; Sung-A Chang; Jidong Sung; Soo Jin Cho; Shin Yi Jang; Yeon Hyeon Choe
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-21       Impact factor: 2.357

6.  The Prognostic Role of Tissue Characterisation using Cardiovascular Magnetic Resonance in Heart Failure.

Authors:  Robert D Adam; James Shambrook; Andrew S Flett
Journal:  Card Fail Rev       Date:  2017-11

Review 7.  Cardiovascular MRI in clinical trials: expanded applications through novel surrogate endpoints.

Authors:  Alex Pitcher; Deborah Ashby; Paul Elliott; Steffen E Petersen
Journal:  Heart       Date:  2011-06-29       Impact factor: 5.994

8.  Thrombus aspiration during primary percutaneous coronary intervention is associated with reduced myocardial edema, hemorrhage, microvascular obstruction and left ventricular remodeling.

Authors:  Mohammad I Zia; Nilesh R Ghugre; Kim A Connelly; Subodh B Joshi; Bradley H Strauss; Eric A Cohen; Graham A Wright; Alexander J Dick
Journal:  J Cardiovasc Magn Reson       Date:  2012-03-26       Impact factor: 5.364

9.  Quantification of infarct size and myocardium at risk: evaluation of different techniques and its implications.

Authors:  Elisa McAlindon; Maria Pufulete; Chris Lawton; Gianni D Angelini; Chiara Bucciarelli-Ducci
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-03-02       Impact factor: 6.875

Review 10.  The Role of Cardiac MRI in Patients with Troponin-Positive Chest Pain and Unobstructed Coronary Arteries.

Authors:  Amardeep Ghosh Dastidar; Jonathan C L Rodrigues; Nauman Ahmed; Anna Baritussio; Chiara Bucciarelli-Ducci
Journal:  Curr Cardiovasc Imaging Rep       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.